Showing results (1311-1320 of 1,398) with videos related to
Sort By:
Pageof 140
European Journal of Medicinal Chemistry|September 22, 2019
Design, synthesis and biological evaluation of cinnamic acid derivatives with synergetic neuroprotection and angiogenesis effectWen-Xi Zhang, Hui Wang, He-Rong Cui, et al.Chinese Medicine|January 23, 2024
The effects of Chinese proprietary medicine and vaccination on patients with COVID-19: a retrospective study in MacaoHui Mo, Man-Fei Zhou, Edmundo Patricio Lopes Lao, et al.Lung Cancer (Amsterdam, Netherlands)|May 12, 2018
EGFR-TKIs plus chemotherapy demonstrated superior efficacy than EGFR-TKIs alone as first-line setting in advanced NSCLC patients with EGFR mutation and BIM deletion polymorphismSangtian Liu, Yayi He, Tao Jiang, et al.Oncotarget|November 21, 2015
Mutant p53 induces EZH2 expression and promotes epithelial-mesenchymal transition by disrupting p68-Drosha complex assembly and attenuating miR-26a processingFei-Zhou Jiang, Yin-Yan He, Hui-Hui Wang, et al.Science Advances|September 14, 2020
Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunityJingjing Liang, Huifang Wang, Wenxiu Ding, et al.Nature Communications|November 12, 2021
The parent-of-origin lncRNA MISSEN regulates rice endosperm developmentYan-Fei Zhou, Yu-Chan Zhang, Yu-Meng Sun, et al.Translational Lung Cancer Research|September 21, 2020
Impact of ALK variants on brain metastasis and treatment response in advanced NSCLC patients with oncogenic ALK fusionMeng Qiao, Chao Zhao, Qian Liu, et al.Acta Pharmacologica Sinica|April 24, 2023
Aurantio-obtusin ameliorates obesity by activating PPARα-dependent mitochondrial thermogenesis in brown adipose tissuesYi-Jie Li, Rui-Yu Wu, Run-Ping Liu, et al.Frontiers in Psychiatry|January 30, 2026
The causal relationship between mental illness-related stigma and mental health knowledge among adolescents at different educational stages: a longitudinal cross-lagged studyYi-Yue Yang, Ke Zhao, Cong Wang, et al.Journal of Medicinal Chemistry|June 25, 2014
Optimization of pyrrolamide topoisomerase II inhibitors toward identification of an antibacterial clinical candidate (AZD5099)Gregory S Basarab, Pamela J Hill, C Edwin Garner, et al.Pageof 140